Dtap Vaccine Market accounted for USD 3.26 Billion in 2020 and is reach USD 5.51 Billion by 2028, registering a CAGR of 6.84% through the forecast period.
Dtap Vaccine Market accounted for USD 3.26 Billion in 2020 and is reach USD 5.51 Billion by 2028, registering a CAGR of 6.84% through the forecast period. The DTaP vaccine market is likely to be driven by the introduction of combination vaccines recommended for immunization programs to reduce the number of injections required while fulfilling immunization compliance in infants. DTaP vaccine targets three diseases at once, namely, diphtheria, tetanus, and pertussis. The demand for D&T containing vaccines accounted for 945 million doses in 2017. In 2018, almost 86 % of infants worldwide received three doses of DTP3 (diphtheria-tetanus-pertussis 3) vaccine, saving them from infectious diseases, which could result in severe illness and disability, when these infants grow up. However, 151 000 cases of pertussis were still registered globally in 2018.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1284
Factors such as high birth rate and the growing popularity of pertussis vaccination, are anticipated to propel the pertussis vaccine market which in turn would have a positive impact on the DTaP vaccine market globally. According to a survey by WHO in 2015, 126 countries had achieved a minimum 90% coverage of the vaccine. Besides, injuries caused by these vaccines is likely to impede the growth of the global market. In the U.S. in 2015, there had been seven claims registered in the federal VICP (Vaccine Injury Compensation Program) on account of post-pertussis vaccination injuries and deaths, comprising three deaths and four serious injuries.
There is a growing demand for vaccines to prevent the occurrence of diseases such as diphtheria, tetanus and pertussis. These factors are projected to boost the market demand for this vaccine combination in the forecast period. Since 2012, UNICEF has obtained small quantities of DTaP vaccine for Armenia, procuring a supply from a single manufacturer. Nevertheless, since 2014, several countries, particularly MICs that usually self-procure, have expressed interest in obtaining aP-containing combination vaccines for their immunization programs through UNICEF, due to apparent difficulties in getting sufficient DTaP-containing combination vaccine supplies through their regular procurement channels.
Various initiatives being taken by governments across the globe to promote the awareness of vaccination benefits through immunization programs is projected to propel the growth of the market in the upcoming years.
The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. The report clearly depicts the current global economic landscape and the considerable situation of the healthcare industry. A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research & development activities, and new drug pipelines are among the key factors that have driven the global pharma & healthcare industry growth in the recent past. Growing acceptance of telehealth and telemedicine services, rise in government initiatives for COVID-19 vaccine development, and escalating demand for advanced point-of-care diagnostics and home healthcare products have further bolstered the industry growth.
The Companies Profiled in The Report:
GlaxoSmithKline, Sanofi Pasteur, Protein Sciences Corporation, Novartis AG, Merch Sharp & Dohme Corp., Pfizer Inc., Astellas Pharma US, Sanofi Aventis, AstraZeneca, and Emergent Biosolution Inc. among others.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/dtap-vaccine-market
Further key findings from the report suggest
- By disease type, the use of the vaccine in treating Pertussis is anticipated to witness a significant growth rate of 7.0% during the forecast period as childhood vaccination is one of the safest and cost-effective ways for the pertussis-free environment.
- Kinrix is forecasted to hold a significant share of the market with a growth rate of 6.9% during the forecast period.
- North America contributes to the largest market share in 2020. In the U.S., coverage with DTaP vaccines differ across age groups. Vaccination coverage for children aged 19 to 35 months of age remains consistently high, at 95.0% for ≥3 DTaP dosages and 84.6% for ≥4 DTaP dosages reported in 2015. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S.
- The Europe and Asia Pacific markets follow the North America market in terms of market dominance.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1284
For the purpose of this report, Reports and Data have segmented global DTaP Vaccine market on the basis of disease type, product type, end-user, and region:
Disease Type Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
- Diphtheria
- Tetanus
- Pertussis
Product Type Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
- Daptacel
- Infanrix
- Kinrix
- Pediarix
- Pentacel
- Quaracel
End-user Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
- Hospitals
- Clinics
- Vaccination Centers
Regional Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
- North America
- U.S.
- Europe
- UK
- France
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1284
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports by Reports and Data’s:
Live Attenuated Vaccines Market Information, By Type (Bacterial, Viral), By Vaccine Development (Tissue Culture, Embryonated Eggs, Live Animals) and End Users (Hospitals, Clinics, Diagnostic Centers, Research Institute, Others), and By Region Forecast to 2028
Global Medical Transcription Market by Type (Outsourcing, Offshoring), By Application (Hospitals, Clinical Laboratories, Academic Medical Centers, Other) And By Region: Forecast to 2028
Examination Nitrile Gloves Market by Type (Non-powdered Gloves, Powdered Gloves), By Application (Hospitals and Clinics) and By Region Forecast To 2028
Nanoparticle Drug Delivery Systems Market By Type (Polymeric, Inorganic, Viral, Lipid-based, Nanoparticle Albumin-bound), By Application (Neurology, Oncology, Cardiovascular, Immunology, Anti-infective, Others), and By Region
Genotyping Assay Market , By Product & Services (Reagents & Kits, Genotyping Services, Instruments, Bioinformatics), By Technology (PCR, Sequencing, Microarrays, Capillary Electrophoresis, MALDI-TOF, NGS, Others), By Application, End-Use, and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs